Skip to main content
    I

    Inhibrx Biosciences, Inc. (INBX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $74.18
    -3.48 (-4.48%)

    Market Cap: $1.14B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Inhibrx Biosciences, Inc. (INBX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Inhibrx Biosciences (INBX) has a latest price of $74.18 on Nov 17, 2026, 52.2% below its 52-week high of $155.29. Its price fell 6.3% over the past 12 months.

    Price Chart

    From May 2024 to Oct 2026, its highest month-end close was $129.21 in Apr 2026 and its lowest $12.33 in Apr 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart INBX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INBX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 26.9%, and over 6 months it fell 32.3%.

    PeriodChange
    1 month-17.4%
    3 months-26.9%
    6 months-32.3%
    12 months-6.3%
    12 months, with dividends-6.3%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$71.78-9.1%
    2025$79.00+413.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 20.7% below its 50-day average of $93.59 and 19.9% below its 200-day average of $92.66.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$74.18
    52-week high$155.29-52.2%
    52-week low$57.30+29.5%
    50-day average$93.59-20.7%
    200-day average$92.66-19.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 49.4%.

    MeasureValue
    1-year beta2.17
    Largest fall, 1 year-49.4%
    Largest fall, 3 years-49.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About INBX

    What is INBX's 1-year price change?

    Inhibrx Biosciences's price fell 6.3% over the past 12 months. With dividends included, the 12-month total return was -6.3%.

    What is INBX's 52-week high and low?

    Inhibrx Biosciences's 52-week high is $155.29 and its 52-week low is $57.30. Its latest price of $74.18 on Nov 17, 2026 is 52.2% below the high.

    What is INBX's beta?

    Inhibrx Biosciences's 1-year beta against the S&P 500 is 2.17, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 49.4%.

    Is the INBX chart free?

    Yes. Advanced Charting for INBX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.